awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q53209584-014306FE-47A0-4564-90CA-A89A92E36754
Q53209584-014306FE-47A0-4564-90CA-A89A92E36754
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53209584-014306FE-47A0-4564-90CA-A89A92E36754
Long-term clinical benefit from salvage EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer patients with EGFR wild-type tumors.
P2860
Q53209584-014306FE-47A0-4564-90CA-A89A92E36754
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53209584-014306FE-47A0-4564-90CA-A89A92E36754
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c1c46833e04543da18fb2133c65b7e70ab45bec9
P2860
Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer.